newsfilter
← Latest News
GlobeNewswire·

Arvinas to Report Third Quarter 2025 Financial Results on November 5, 2025

NEW HAVEN, Conn., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that